Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07324239

TECAR Therapy on Pain and Quality of Life in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Evaluate the effect of TECAR therapy on pain, voiding, erectile function, sleep quality and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Prostatitis Genital Diseases Genital Diseases, Male Male Urogenital Diseases Prostatic Diseases Urogenital Diseases

Age range

30 year–50 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Tanta University Hospital

Tanta, Egypt

Location contact

Mohamed Rady Ewis

CONTACT

[email protected]

About this study

Sixty men with chronic prostatitis/chronic pelvic pain will be sourced from the urology outpatient clinic at Tanta University hospitals in Egypt, with referrals from urologists. Patients will be randomly assigned into two groups.

Study group: It will include 30 men receiving true TECAR therapy plus dietary and life style adjustments.

Control group: It will include 30 men receiving sham TECAR therapy plus dietary and life style adjustments.

Evaluation Procedures:

  • Pain, voiding, and quality of life using the National Institutes of Health-Chronic Prostatitis Symptom Index.
  • Sleep quality using the Pittsburgh Sleep Quality Index.
  • Erectile function using the International Index of Erectile Function.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Presence of chronic prostatitis/chronic pelvic pain symptoms for more than 6 months.
  • Ages will be ranged from 30 to 50 years old.

Exclusion criteria

  • Urinary and seminal infections.
  • Recent parenteral steroid administration.
  • Prior prostate or pelvic surgery.
  • Lower urinary tract disorders such as bladder stones.
  • Implanted electronic devices as pacemakers.
  • Sensory loss over the perineum.

Treatment and study plan

TECAR Therapy

Device

WINBACK 3SE (France) will be used for TECAR therapy in this study. To facilitate optimal distribution of endogenous heat therapy and effective contact between the active electrodes, both capacitive and resistive, and the surface of the skin, a layer of high-conductivity cream will be applied to the treatment region. The plate, an inactive electrode, which has a specific size (21cm*15cm), will be placed on the gluteal region. The capacitive electrode was employed for a duration of seven and a half minutes, at an intensity of 30-40%, whereas the resistance electrode will be utilized for an equivalent period over the perineum at the same intensity.

Sham TECAR therapy

Device

The procedure is similar to the active treatment of TECAR, but with the critical difference being that the output intensity of the TECAR device will be set to zero during the session.

Primary outcomes

  1. Pelvic pain

    Time frame: Baseline and 8 weeks later

    Pain will be assessed using the National Institutes of Health-Chronic Prostatitis Symptom Index

Secondary outcomes

  1. Quality of life of men

    Time frame: Baseline and after 8 weeks

    Quality of life will be assessed using the National Institutes of Health-Chronic Prostatitis Symptom Index

Study contacts

Contact information is provided by the study sponsor or research team.

Mohammed Elhamrawy, Ph.D

CONTACT

Saher Elgayar, Ph.D

CONTACT

[email protected]

+201020429911

Sponsors and collaborators

Lead sponsor

Middle East University

Other

Registry information

Official study title

Effect of TECAR Therapy on Pain and Quality of Life in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: a Randomized Controlled Trial

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jan 7, 2026
Registry last updated
Jan 7, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.